Sign in
4

Changes in Ownership

Bioventus Inc. Filed Acc 0000899243-22-006541

SVP & CFO sold 1,294 shares at $11.99 ($15,518)

  • SVP & CFO acquired 4,400 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Anglum Gregory O. · SVP & CFO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-02-11 Exercise or conversion : show line 1 in the form +4,400 56,307 D
2022-02-14 Sale : show line 2 in the form −1,294 $11.99 $15,518 55,013 D
Open-market sales · 1,294 sh · avg $11.99 · $15,518

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-02-11 Exercise or conversion : show line 3 in the form Restricted Stock Units −4,400 0 D
Loading xslF345X03/doc4.xml…